Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U18) - Clinical Trails Not Allowed

The summary for the Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U18) - Clinical Trails Not Allowed grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.

Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U18) - Clinical Trails Not Allowed: The Food and Drug Administration's (FDA) Center for Food and Safety and Applied Nutrition (CFSAN) is announcing its intention to receive and consider a single source application for the award of a cooperative agreement in fiscal year 2024 to Cornell University to support the Center for Veterinary Medicine and the College of Agricultural and Life Sciences. The purpose of this support is to:1. Carry out multidisciplinary applied research projects on raw milk cheese aging to examine factors that affect Highly Pathogenic H5N1 Avian Influenza (HPAI H5N1) virus inactivation, to include pH and water activity.2. Carry out multidisciplinary applied research projects on commonly used acidification methods for treatment of waste milk to be fed to calves, or for disposal, to understand effects on HPAI H5N1.3. Carry out multidisciplinary applied research projects to characterize the thermal inactivation kinetics of HPAI H5N1 in a wide variety of dairy products.4. Provide additional capabilities and capacity for HPAI H5N1 testing as needed to help meet the needs of FDA's research agenda. 5. Engage with academic and industry stakeholders to help ensure work is complementary of other ongoing research in these research spaces and to facilitate the use of the information produced by the research program.